CoChat
Sign Up
Cited by 283Opioid Use Disorder TreatmentPain Management and Opioid UseNeuropeptides and Animal Physiology

The DOI matches its Crossref record.

Acute administration of buprenorphine in humans: partial agonist and blockade effects.

Walsh, S L, Preston, K L, Bigelow, G E, Stitzer, M L·1995·The Journal of Pharmacology and Experimental Therapeutics
DOI 10.1016/s0022-3565(25)10510-7
Open this paper in CoChat — free account

Abstract

Buprenorphine, a mixed opioid agonist-antagonist, is being investigated as a treatment for opioid dependence. This study compared the acute subjective and physiological effects of sublingual buprenorphine to those of p.o. methadone over a wide range of doses and compared the ability of both drugs to alter the effects of an opioid challenge. Male inpatient volunteers (n = 9) with histories of opioid abuse participated in this double-blind, double-dummy study. Sublingual buprenorphine (0, 0.5, 2, 8, 16 and 32 mg) and p.o. methadone (3.75, 15 and 60 mg) were administered once weekly according to a Latin-square design, and subjects were monitored on a variety of physiological and subjective measures. Twenty-four hours later, subjects were tested with ascending doses of i.m. hydromorphone (0, 1 and 4 mg) given 45 min apart. Buprenorphine and methadone produced typical opioid agonist effects of long duration, including pupillary constriction, respiratory depression and elevations on subject-rated and observer-rated indices of euphoria, sedation and opioid-like symptoms. The buprenorphine dose-effect curves were nonlinear and maximal effects for most physiological and subjective measures were observed between 4 and 8 mg, with no greater effects observed at higher doses. The methadone dose-effect curves were linear across the range of doses tested. High doses of buprenorphine and methadone both attenuated the response to hydromorphone challenge 24 hr later. These data indicate that there is a ceiling on the effects of buprenorphine in humans that may reduce its abuse liability and increase its safety, and indicate that opioid blockade occurs after acute administration of buprenorphine or methadone.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)10510-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

Sorted by citations

Items 201–278 of 278

Related

See all

Metadata

Authors
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L.
Affiliations
Johns Hopkins University (US)
ORCID
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1995-07
Volume
274
Issue
1
Pages
361-372
ISSN
0022-3565 (ISSN-L)
DOI
10.1016/s0022-3565(25)10510-7
OpenAlex
W2097145370
Cited by
283
References
0
Citations by year
2025: 6 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 12 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 9 · 2012: 11
FWCI
9.36
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed
Funders
  • National Institutes of Health (5r18da006165-05, 5r18da006120-05)
  • National Institute on Drug Abuse (R18 DA 06165, K05DA000050, R18 DA06120)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
buprenorphine, methadone, opioid agonist-antagonist, opioid blockade, opioid use disorder, opioid abuse, sublingual administration, dose-response relationship, ceiling effect, respiratory depression, miosis, euphoria, sedation, abuse liability
MeSH terms
Adult, Buprenorphine, Hydromorphone, Double-Blind Method, Humans, Male, Methadone, Narcotic Antagonists, Receptors, Opioid, Respiration, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review